{"DataElement":{"publicId":"4986315","version":"1","preferredName":"Stomach Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage","preferredDefinition":"Extent of the distant metastasis for the gastric neuroendocrine tumor based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"4985375v1.0:4986133v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"4985375","version":"1","preferredName":"Gastric Neuroendocrine Neoplasm Pathologic M Stage","preferredDefinition":"A neoplasm with neuroendocrine differentiation that arises from the stomach.  It includes well differentiated neuroendocrine tumors (low and intermediate grade) and poorly differentiated neuroendocrine carcinomas (high grade)._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system.  M refers to the presence of metastasis.","longName":"4985363v1.0:2207807v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"4985363","version":"1","preferredName":"Gastric Neuroendocrine Neoplasm","preferredDefinition":"A neoplasm with neuroendocrine differentiation that arises from the stomach.  It includes well differentiated neuroendocrine tumors (low and intermediate grade) and poorly differentiated neuroendocrine carcinomas (high grade).","longName":"C5696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Neoplasm","conceptCode":"C5696","definition":"A neoplasm with neuroendocrine differentiation that arises from the stomach. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E29E3CB-E13B-8112-E050-BB89AD432902","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2B1F3A-D14B-5724-E050-BB89AD435649","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4986133","version":"1","preferredName":"Gastric Neuroendocrine Tumor American Joint Committee on Cancer (AJCC) Edition 7 Pathologic M Stage","preferredDefinition":"A pathologic finding about one or more characteristics of gastric neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for gastric neuroendocrine tumor. (from AJCC 7th Ed.)_The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"4986133v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1","valueDescription":"Gastric Neuroendocrine Tumor pM1 TNM Finding v7","ValueMeaning":{"publicId":"4986135","version":"1","preferredName":"Gastric Neuroendocrine Tumor pM1 TNM Finding v7","longName":"4986135","preferredDefinition":"Gastric neuroendocrine tumor with distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor pM1 TNM Finding v7","conceptCode":"C90081","definition":"Gastric neuroendocrine tumor with distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7B48-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E3996DA-7B61-308A-E050-BB89AD435DB5","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4986132","version":"1","preferredName":"Gastric Neuroendocrine Tumor Pathologic Distant Metastasis TNM Finding v7 Stage","preferredDefinition":"A pathologic finding about one or more characteristics of gastric neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for gastric neuroendocrine tumor. (from AJCC 7th Ed.):The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C90080:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neuroendocrine Tumor Pathologic Distant Metastasis TNM Finding v7","conceptCode":"C90080","definition":"A pathologic finding about one or more characteristics of gastric neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for gastric neuroendocrine tumor. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7B1C-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"ONEDATA","dateModified":"2015-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E3996DA-7B2D-308A-E050-BB89AD435DB5","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"COOPERM","dateModified":"2015-09-22","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"4985894","version":"1","longName":"Neuroendocrine","context":"NCIP"},{"publicId":"4985891","version":"1","longName":"Stomach","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777526","version":"1","longName":"Neuroendocrine ","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic M Stage","type":"Preferred Question Text","description":"Pathologic M Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"1E3B406F-4893-408D-E050-BB89AD430537","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-26","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created by COG request for their APEC14B1 study in Rave. mc 8/26/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}